Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jelena Mann

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Hepatology (Baltimore, Md.)|July 7, 2021
A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against HepatosteatosisMarina Garcia-Macia, Adrián Santos-Ledo, Jack Leslie, et al.
Bioscience Reports|May 29, 2024
UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosisAmy Collins, Rebecca Scott, Caroline L Wilson, et al.
Gut|January 29, 2018
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damageMaria J Perugorria, Aitor Esparza-Baquer, Fiona Oakley, et al.
Rheumatology (Oxford, England)|July 30, 2020
cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosisJulie C Worrell, Jack Leslie, Graham R Smith, et al.
The FEBS Journal|March 14, 2025
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsMaria Teresa Borrello, Dusan Ruzic, Hannah Paish, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver SlicesHannah L Paish, Lee H Reed, Helen Brown, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Gastroenterology|December 14, 2020
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic HepatitisVeronica Massey, Austin Parrish, Josepmaria Argemi, et al.
The Journal of Clinical Investigation|July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoterAdèle Hannigan, Paul Smith, Gabriela Kalna, et al.
The EMBO Journal|February 10, 2019
Length-independent telomere damage drives post-mitotic cardiomyocyte senescenceRhys Anderson, Anthony Lagnado, Damien Maggiorani, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Hepatology (Baltimore, Md.)|July 7, 2021
A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against HepatosteatosisMarina Garcia-Macia, Adrián Santos-Ledo, Jack Leslie, et al.
Bioscience Reports|May 29, 2024
UCHL1-dependent control of hypoxia-inducible factor transcriptional activity during liver fibrosisAmy Collins, Rebecca Scott, Caroline L Wilson, et al.
Gut|January 29, 2018
Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damageMaria J Perugorria, Aitor Esparza-Baquer, Fiona Oakley, et al.
Rheumatology (Oxford, England)|July 30, 2020
cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosisJulie C Worrell, Jack Leslie, Graham R Smith, et al.
The FEBS Journal|March 14, 2025
Pharmacological manipulation of liver fibrosis progression using novel HDAC6 inhibitorsMaria Teresa Borrello, Dusan Ruzic, Hannah Paish, et al.
Hepatology (Baltimore, Md.)|April 10, 2019
A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver SlicesHannah L Paish, Lee H Reed, Helen Brown, et al.
Gut|April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosisMarina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Gastroenterology|December 14, 2020
Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic HepatitisVeronica Massey, Austin Parrish, Josepmaria Argemi, et al.
The Journal of Clinical Investigation|July 2, 2010
Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoterAdèle Hannigan, Paul Smith, Gabriela Kalna, et al.
The EMBO Journal|February 10, 2019
Length-independent telomere damage drives post-mitotic cardiomyocyte senescenceRhys Anderson, Anthony Lagnado, Damien Maggiorani, et al.
Pageof 8